Topic - Chris Viehbacher

Related Stories

FILE - In this Feb. 11, 2009 file photo, Chris Viehbacher CEO of Sanofi-Aventis SA, gestures while announcing the 2008 full year result in Paris. French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion Wednesday, Feb. 16, 2011, ending months of corporate haggling. (AP Photo/Michel Euler, file)

Sanofi-Aventis to buy Genzyme for $20.1 bln cash

By GREG KELLER - Associated Press

Sanofi-Aventis sticking to first offer for Genzyme

By LINDA A. JOHNSON - Associated Press